Nucleic Acids Research, 1994, Vol. 22, No. 9 1583-1592
© 1994
MOLECULAR BIOLOGY |
Expression from the tyrosine aminotransferase promoter (nt 350 to +1) is liver-specific and dependent on the binding of both liver-enriched and ubiquitous trans-acting factors
CNRS Institut Jacques Monod and INSERM U 257, Couloir 4243, 2 Place Jussieu, 75251 Paris 1INSERM U 33, 80 rue du Général Leclerc, 94276 Le Kremlin-Bicêtre Cedex, France
*To whom correspondence should be addressed
Received February 10, 1994. Revised March 24, 1994. Accepted March 24, 1994.
The rat tyrosine aminotransferase (TAT) gene promoter (nucleotides 350 to +1; TAT0.35) was able to sustain liver-specific expression both ex vivo in transient transfection (TAT-expressing H4IIEC3 hepatoma cells vs. TAT non-expressing CCL1.2 fibroblasts) and in in vitro transcription (rat liver vs. spleen crude nuclear extracts). In either case, the index of tissue specificity (6.2 and 6.7 in ex vivo and in vitro experiments, respectively) was close to that obtained with 10 Kb of TAT gene 5'-flanking sequences in transient transfection. Using computer-assisted search of homologies, DNase I footprinting, gel retardation and methylation interference assays, we showed that TAT0.35 sequences spanning nt 156 to 175 and nt 268 to 281 interacted with the liver enriched NF-1Liver (a member of the NF1 gene family) and HNF1 respectively, whereas those encompassing nt 57 to 85 and nt 283 to 288 interacted with the ubiquitous NF-Y and with ubiquitous CCAAT-box binding factor(s), respectively. Competition studies in in vitro transcription carried out with wild type and mutated oligonucleotides, demonstrated that NF-Y cis-elements were crucial for basal TAT promoter activity, both in liver and spleen whereas NF1Liver and HNF1 were only efficient in the liver (supported
60% and 30% of basal TAT0.35 activity respectively). Altogether, these results support the conclusion that TAT0.35 was able to sustain at least part of the liver specificity of TAT gene expression.
+Present address: INSERM U142, Hôpital Saint Antoine, 75571 Paris Cedex 12, France
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Sato, K. Miyake, H. Kaneoka, and S. Iijima Sumoylation of CCAAT/Enhancer-binding Protein {alpha} and Its Functional Roles in Hepatocyte Differentiation J. Biol. Chem., August 4, 2006; 281(31): 21629 - 21639. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Leib, T. C. McGuire, and D. J. Prieur Comparison of the Tyrosine Aminotransferase cDNA and Genomic DNA Sequences of Normal Mink and Mink Affected with Tyrosinemia Type II J. Hered., July 1, 2005; 96(4): 302 - 309. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liberati, A. Ronchi, P. Lievens, S. Ottolenghi, and R. Mantovani NF-Y Organizes the gamma -Globin CCAAT Boxes Region J. Biol. Chem., July 3, 1998; 273(27): 16880 - 16889. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Alonso, C. G. Pesce, and A. R. Kornblihtt The CCAAT-binding Proteins CP1 and NF-I Cooperate with ATF-2 in the Transcription of the Fibronectin Gene J. Biol. Chem., September 6, 1996; 271(36): 22271 - 22279. [Abstract] [Full Text] [PDF] |
||||

